Search the Newsreel

Cellectar Biosciences (CLRB) ownership: Bleichroeder group reports 9.99% equity stake

Bleichroeder entities, led by Bleichroeder LP and Andrew Gundlach, have reported a 9.99% equity stake in Cellectar Biosciences (CLRB), amounting to 808,300 common shares. Bleichroeder LP, a registered investment adviser, holds these shares for various advisory clients, granting them sole voting and dispositive power …

BioXcel Therapeutics (BTAI) flags going concern risk with high debt and cash strain

BioXcel Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Celcuity GAAP EPS of -$1.44 misses by $0.28

* Celcuity press release [https://seekingalpha.com/pr/20619145-celcuity-inc-reports-release-of-second-quarter-2026-financial-results-and-provides-corporate] (CELC [https://seekingalpha.com/symbol/CELC]): Q2 GAAP EPS of -$1.44 misses by $0.28. * Total operating expenses were $66.1 million for the second quarter of 2026, compared to $44.0 million for the prior year period. Research and development (“R&D”) expenses were $31.1 …

Earnings Flash (CELC) Celcuity Inc. Posts Q2 Adjusted Loss $1.07 per Share, vs. FactSet Est of $-1.12

Celcuity Inc. (CELC) reported a Q2 adjusted loss of $1.07 per share, which was better than the FactSet estimate of $-1.12 per share. The article, published on August 13, 2026, also noted that Celcuity's Q2 adjusted loss widened. This news follows several recent developments …

ImmuCell Plans About $4.5M Expansion for Calf Health Products

ImmuCell (NASDAQ: ICCC) reported strong Q2 2026 financial results with product sales up 11.5% to $7.2 million and net income rising to $1.8 million, aided by a $2 million legal settlement. The company announced a two-phase, approximately $8.0 million expansion of its First Defense® …

ImmuCell Corporation (ICCC) doubles profit on higher First Defense sales

ImmuCell Corporation reported robust financial results for the first half of 2026, with net income doubling to $3.8 million due to increased First Defense sales and a significant $2.0 million settlement. The company's product sales grew by 20.9% to $17.5 million, largely driven by …

FuelCell Energy (NASDAQ:FCEL) Shares Down 7.1% - Here's What Happened

FuelCell Energy (NASDAQ:FCEL) shares dropped 7.1% on Thursday, closing at $20.13, with trading volume below average. The company reported a significant quarterly loss and lower-than-expected revenue. Analyst sentiment is mixed, resulting in a consensus "Hold" rating and an average price target of $22.83.

Energy company locks Colorado mom’s thermostat during scorching heat wave — ‘not safe’

A Colorado woman, Kyri Baker, found her thermostat locked by Xcel Energy during a heatwave, preventing her from lowering her home's temperature below 79 degrees. This occurred despite her voluntary enrollment in Xcel's Saver's Switch program, which offers a $40 monthly credit for allowing …

Xcel Brands Revenue Falls 14% as Q2 Net Loss Narrows

Cellebrite (CLBT) boosts H1 2026 revenue 17% while net income falls sharply

Accelerant Holdings Class A Common Shares (NYSE:ARX) Stock Quote

This article provides a stock quote and recent news for Accelerant Holdings Class A Common Shares (NYSE:ARX). It highlights the company's current stock price, trading volume, performance metrics, and a series of news headlines, including a recent surge due to a $4 billion all-cash …

Turkcell Iletisim Hizmetleri AS (NYSE:TKC) Issues Quarterly Earnings Results

ICCC Q1 2026 Earnings: Reports $0.21 EPS, Shares Gain $0.23 - Analyst Consensus Shift

Bolstered by PepsiCo Partnership, Celsius' Growth Outlook Looks Strong Despite Near-Term Volatility

Celsius Holdings' growth outlook remains strong due to its long-term partnership with PepsiCo and the acquisition of Alani Nu, which helps tap into female consumer demand. Despite these positives, Morningstar analysts express skepticism about Celsius establishing a durable competitive position given the intense competition …

Shareholder Alert: Ademi LLP investigates whether Accelerant Holdings is obtaining a Fair Price for Public Shareholders

Ademi LLP is investigating Accelerant Holdings (NYSE: ARX) for potential breaches of fiduciary duty related to its recently announced transaction with Thoma Bravo. The firm is concerned about whether public shareholders are receiving a fair price of $20.25 per share, especially given the substantial …

Cellebrite Q2: This 33% Selloff Looks Like An Overreaction (NASDAQ:CLBT)

Cellebrite DI Ltd. (CLBT) experienced a significant 33% stock drop post-earnings, which the author believes is an overreaction. Despite missing Q2 guidance for ARR and revenue growth, and facing management transition and slower Inseyets conversions, the company maintains strong core products, high retention, and …

Cellebrite DI Releases Q2 2026 Financial Results

Cellebrite DI Ltd. reported mixed Q2 2026 financial results, with earnings per share meeting expectations at $0.11, while revenue of $131.1M slightly missed the $131.9M estimate. Despite the revenue miss, the company showed strong year-over-year growth, with total revenue up 16.0% and subscription services …

Accelerant Q2 Earnings Beat Estimates on Strong Premium Growth

Accelerant Holdings ARX reported second-quarter fiscal 2026 adjusted earnings of 32 cents per share, which more than doubled from 13 cents reported in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate of 16 cents. Operating revenues increased 62.9% year over year …

Transcript : Turkcell Iletisim Hizmetleri A.S., Q2 2026 Earnings Call, Aug 13, 2026

Axcelis (ACLS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, August 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Senior Vice President and Interim Chief Financial Officer - David RyzhikPresident and CEO - Russell Low TAKEAWAYS Revenue -- $215.2 million, exceeding company forecasts due to stronger system …

AbCellera Biologics Inc. • Robinhood Token (ABCL) Price Prediction for 2026 to 2031

This article provides price predictions for AbCellera Biologics Inc. • Robinhood Token (ABCL) from 2026 to 2045, based on Bybit AI's analysis of user-driven Consensus Ratings and historical patterns. It forecasts a positive trend for ABCL's price, with significant potential ROI over the years, …

CLRB Q1 2026 Earnings: Narrower-Than-Expected Loss of $1.30 Per Share as Development Focus Intensifies

Celestica Inc Stock (CLS) Moved Up by 7.15% on Aug 13: Drivers Behind the Movement

Celestica Inc (CLS) stock rose by 7.15% on August 13th, outperforming its sector. This surge was primarily driven by strategic capital injection from a recent equity offering, strong operational execution with upgraded guidance, and favorable institutional and analyst commentary highlighting its crucial role in …

Turkcell Iletisim Hizmetleri Q2 Earnings Fall, Revenue Rises

Celestica Inc. (CLS) awards 190 D-RSUs to board director Colpitts

Celestica Inc. director Christopher W. Colpitts was granted 190 Director Restricted Share Units (D-RSUs) on August 11, 2026, as part of his equity-based compensation. These D-RSUs vest on May 20, 2027, bringing his directly held D-RSU balance to 1,000 units. Each D-RSU represents a …

Why is Accelerant Holdings stock surging today?

Accelerant Holdings stock surged 43.5% today after announcing a take-private deal with Thoma Bravo, valued at over $4 billion, and reporting a significant Q2 2026 earnings beat. The all-cash transaction offers shareholders a 49% premium to the previous day's closing price, with entities controlling …

Turkcell mobile base tops 40 million after 243,000 additions

Turkcell announced its Q2 2026 earnings, reporting consolidated revenues of TRY 71.8 billion, a 2.5% year-on-year increase, and an EBITDA of TRY 30.0 billion with a 41.8% margin. The company's mobile subscriber base exceeded 40 million for the first time, adding 243,000 subscribers in …

Turkcell Iletisim Hizmetleri: Second Quarter 2026 Results

Diversified and Resilient Business Model Delivers Steady Growth ISTANBUL, August 13, 2026--(BUSINESS WIRE)--Turkcell (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell İletişim Hizmetleri A.S. (the "Company" or "Turkcell") and its subsidiaries and associates (together referred to as …

Turkcell Iletisim Hizmetleri A.S. Maintains Earnings Guidance for the Year 2026

Celcuity LLC (CELC) enters earnings with mixed weekly signals

A near-term rebound contrasts with deeper medium-term losses before the oncology biotech reports.

BTAI Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares Rally 7.08% - Guidance Upgrade Report

Accelerant Holdings stock Analysis: Post-Earnings Rally & Sustainability Check

Turkcell Iletisim Hizmetleri A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Diversified and Resilient Business Model Delivers Steady Growth ISTANBUL, August 13, 2026--(BUSINESS WIRE)--Turkcell (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell İletişim Hizmetleri A.S. (the "Company" or "Turkcell") and its subsidiaries and associates (together referred to as …

BioXcel Deadline Alert

Faruqi & Faruqi, LLP is investigating potential claims against BioXcel Therapeutics, Inc. (NASDAQ: BTAI) and reminds investors of the September 5, 2023, deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit stems from allegations that BioXcel made …

Cellebrite DI Ltd. Stock Analysis: 5-Day Bearish Momentum Insights

Cellebrite DI Ltd. (CLBT) stock has crashed to $10.22 following a post-earnings decline, placing it deep in oversold territory according to its RSI readings across multiple timeframes. The company missed annual recurring revenue expectations due to delayed transactions and slower customer migration gains, leading …